BiotechTube

REGN1500 + placebo

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hypertriglyceridemia

Conditions

Hypertriglyceridemia

Trial Timeline

Dec 1, 2012 → Jan 1, 2016

NCT ID
NCT01749878

About REGN1500 + placebo

REGN1500 + placebo is a phase 1 stage product being developed by Regeneron Pharmaceuticals for Hypertriglyceridemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01749878. Target conditions include Hypertriglyceridemia.

What happened to similar drugs?

1 of 20 similar drugs in Hypertriglyceridemia were approved

Approved (1) Terminated (0) Active (19)
✅rosuvastatinAstraZenecaApproved
🔄Placebo + Ethyl IcosapentateSumitomo PharmaPhase 3
🔄Omega-3-Acid Ethyl Esters 90 Soft Capsules + Corn OilJiangsu Hengrui MedicinePhase 3
🔄Olive oil, 4g + omega-3-carboxylic acids, 2g + omega-3-carboxylic acids, 4gAstraZenecaPhase 3
🔄Epanova + Olive OilAstraZenecaPhase 3
🔄AZD0585 + AZD0585 placeboAstraZenecaPhase 3
🔄ABT-143 + simvastatinAstraZenecaPhase 3

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT02107872Phase 1Completed
NCT01749878Phase 1Completed

Competing Products

20 competing products in Hypertriglyceridemia

See all competitors
ProductCompanyStageHype Score
LY3875383 + PlaceboEli LillyPhase 1
21
ZYH7 + ZYH7 + ZYH7 + FenofibrateZydus LifesciencesPhase 2
35
Solbinsiran + PlaceboEli LillyPhase 2
42
Placebo + Ethyl IcosapentateSumitomo PharmaPhase 3
40
Omega-3-Acid Ethyl Esters 90 Soft Capsules + Corn OilJiangsu Hengrui MedicinePhase 3
36
warfarin + omefas + omega-3-acid ethyl estersAstraZenecaPhase 1
29
rosuvastatinAstraZenecaApproved
43
Simvastatin + acetylsalicylic acid (ASA) + omefasAstraZenecaPhase 1
29
Olive oil, 4g + omega-3-carboxylic acids, 2g + omega-3-carboxylic acids, 4gAstraZenecaPhase 3
40
Epanova (4 g) and Lovaza (4 g) + Lovaza (4 g) and Epanova (4 g)AstraZenecaPhase 2
35
rosuvastatin 40 mg tablet + Epanova™ QD (2 x 1 g capsules) + Multiple doses of 4 g Epanova™ with single of rosuvastatin 40 mg dose + Multiple (20) oral doses of 2 g Vascepa® every 12 hoursAstraZenecaPhase 1
29
placebo + omefas + omefas + omefasAstraZenecaPhase 2/3
38
Epanova + LovazaAstraZenecaPhase 1
29
Epanova + Olive OilAstraZenecaPhase 3
40
AZD0585 + AZD0585 placeboAstraZenecaPhase 3
40
ABT-143 + simvastatinAstraZenecaPhase 3
40
MaravirocPfizerPhase 1
29
torcetrapib/atorvastatin + atorvastatinPfizerPhase 3
40
Icosapent (MND-2119) + Icosapent (EPADEL CAPSULES 300)Mochida PharmaceuticalPhase 3
40
IcosapentMochida PharmaceuticalPhase 3
40